Scleroderma Clinical Trials Scleroderma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical Study of Divozilimab in Patients With Systemic Scleroderma
Condition:   Systemic Scleroderma Interventions:   Drug: Divozilimab;   Drug: Placebo Sponsor:   Biocad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2023 Category: Research Source Type: clinical trials